• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nectin-4 通过调节 CXCR4-LYVE-1 轴促进乳腺癌淋巴管生成和淋巴转移。

Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis.

机构信息

Cancer Biology Division, KIIT School of Biotechnology, Kalinga Institute of Industrial Technology, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.

Department of Surgical Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, Odisha 753007, India.

出版信息

Vascul Pharmacol. 2021 Oct;140:106865. doi: 10.1016/j.vph.2021.106865. Epub 2021 May 1.

DOI:10.1016/j.vph.2021.106865
PMID:33945869
Abstract

Tumor-induced lymphangiogenesis promotes tumor progression by generating new lymphatic vessels that helps in tumor dissemination to regional lymph nodes and distant sites. Recently, the role of Nectin-4 in cancer metastasis and angiogenesis has been studied, but its role in lymphangiogenesis is unknown. Here, we systematically delineated the role of Nectin-4 in lymphangiogenesis and its regulation in invasive duct carcinoma (IDC). Nectin-4 expression positively correlated with occurrence risk factors associated with breast cancer (alcohol, smoke, lifestyle habit, etc), CXCR4 expression, and LYVE-1-lymphatic vessel density (LVD). LVD was significantly higher in axillary lymph node (ALN) than primary tumor. Depleting Nectin-4, VEGF-C or both attenuated the important lymphangiogenic marker LYVE-1 expression, tube formation, and migration of ALN derived primary cells. Nectin-4 stimulated the expressions of CXCR4 and CXCL12 under hypoxic conditions in ALN derived primary cells. Further, Nectin-4 augmented expressions of lymphatic metastatic markers (e.g. eNOS, TGF-β, CD-105) and MMPs. Induced expressions of Nectin-4 along with other representative metastatic markers were noted in lymph and blood circulating tumor cells (LCTCs and BCTCs) of local and distant metastatic samples. Thus, Nectin-4 displayed a predominant role in promoting tumor-induced lymphangiogenesis and lymphatic metastasis by modulating CXCR4/CXCL12-LYVE-1- axis.

摘要

肿瘤诱导的淋巴管生成通过生成新的淋巴管促进肿瘤进展,有助于肿瘤向区域淋巴结和远处部位扩散。最近,研究了 Nectin-4 在癌症转移和血管生成中的作用,但它在淋巴管生成中的作用尚不清楚。在这里,我们系统地描述了 Nectin-4 在淋巴管生成中的作用及其在浸润性导管癌 (IDC) 中的调节作用。Nectin-4 的表达与乳腺癌的发生风险因素(酒精、吸烟、生活习惯等)、CXCR4 表达和 LYVE-1-淋巴管密度 (LVD) 呈正相关。腋窝淋巴结 (ALN) 中的 LVD 明显高于原发性肿瘤。敲低 Nectin-4、VEGF-C 或两者都可减弱重要的淋巴管生成标志物 LYVE-1 的表达、管形成和 ALN 衍生的原代细胞的迁移。Nectin-4 在 ALN 衍生的原代细胞中在缺氧条件下刺激 CXCR4 和 CXCL12 的表达。此外,Nectin-4 增强了淋巴转移标志物(如 eNOS、TGF-β、CD-105)和 MMPs 的表达。在局部和远处转移样本的淋巴和血液循环肿瘤细胞 (LCTC 和 BCTC) 中观察到 Nectin-4 与其他代表性转移标志物的诱导表达。因此,Nectin-4 通过调节 CXCR4/CXCL12-LYVE-1-轴,在促进肿瘤诱导的淋巴管生成和淋巴转移方面发挥主要作用。

相似文献

1
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis.Nectin-4 通过调节 CXCR4-LYVE-1 轴促进乳腺癌淋巴管生成和淋巴转移。
Vascul Pharmacol. 2021 Oct;140:106865. doi: 10.1016/j.vph.2021.106865. Epub 2021 May 1.
2
The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.CXCL12-CXCR4 趋化因子通路:调控淋巴管生成的新轴。
Clin Cancer Res. 2012 Oct 1;18(19):5387-98. doi: 10.1158/1078-0432.CCR-12-0708. Epub 2012 Aug 29.
3
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.血管内皮生长因子 C 和 D 诱导的肿瘤周围淋巴管生成促进乳腺癌患者淋巴结转移。
World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.
4
Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease.淋巴结淋巴管生成和转移:肿瘤诱导的淋巴管激活在乳腺外派杰病中的作用。
Am J Pathol. 2009 Nov;175(5):2235-48. doi: 10.2353/ajpath.2009.090420. Epub 2009 Oct 8.
5
[Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].[喉癌中淋巴管生成与临床病理特征及预后的关系]
Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):461-4.
6
Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.采用特异性淋巴管内皮细胞标志物 D2-40 和 LYVE-1 评估精原细胞瘤性睾丸癌中的淋巴管密度:与病理参数和临床结果的相关性。
Urol Oncol. 2013 Oct;31(7):1386-94. doi: 10.1016/j.urolonc.2011.08.006. Epub 2011 Oct 4.
7
Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.Nectin-4 基因在肿瘤转移和血管生成中的临床意义与肿瘤复发。
J Cancer Res Clin Oncol. 2020 Jan;146(1):245-259. doi: 10.1007/s00432-019-03055-2. Epub 2019 Oct 15.
8
The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors.淋巴管密度和淋巴管生成在非精原细胞瘤性睾丸生殖细胞肿瘤转移扩散中的作用。
Urol Oncol. 2014 Feb;32(2):178-85. doi: 10.1016/j.urolonc.2012.08.004. Epub 2012 Nov 7.
9
Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.细胞外热休克蛋白 90α 促进乳腺癌淋巴管生成和淋巴结转移。
Int J Mol Sci. 2021 Jul 20;22(14):7747. doi: 10.3390/ijms22147747.
10
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.CCL21/CCR7趋化因子轴在乳腺癌诱导的淋巴管生成中的作用。
Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

引用本文的文献

1
Exploration of prognostic genes associated with lymphangiogenesis in breast cancer based on transcriptomics and experimental verification.基于转录组学和实验验证探索乳腺癌中与淋巴管生成相关的预后基因
PeerJ. 2025 Aug 27;13:e19890. doi: 10.7717/peerj.19890. eCollection 2025.
2
Lactate Is a Major Promotor of Breast Cancer Cell Aggressiveness.乳酸是乳腺癌细胞侵袭性的主要促进因子。
Cancers (Basel). 2025 May 27;17(11):1793. doi: 10.3390/cancers17111793.
3
Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study.
基于动态对比增强磁共振成像的乳腺癌患者腋窝淋巴结转移预测的瘤周放射组学模型的开发与验证:一项回顾性研究
Quant Imaging Med Surg. 2024 Dec 5;14(12):8211-8226. doi: 10.21037/qims-24-558. Epub 2024 Oct 31.
4
Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects.乳腺癌中Nectin-4的靶向治疗策略:最新进展与未来展望
Breast. 2025 Feb;79:103838. doi: 10.1016/j.breast.2024.103838. Epub 2024 Nov 14.
5
Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.透明质酸相互作用分子介导的癌细胞与从原发性肿瘤到远处转移的微环境之间的串扰
Cancers (Basel). 2024 May 16;16(10):1907. doi: 10.3390/cancers16101907.
6
Therapeutic prospects of nectin-4 in cancer: applications and value.Nectin-4在癌症治疗中的前景:应用与价值
Front Oncol. 2024 Mar 28;14:1354543. doi: 10.3389/fonc.2024.1354543. eCollection 2024.
7
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.淋巴管:起源、异质性、生物学功能和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x.
8
A novel portable immuno-device for the recognition of lymphatic vessel endothelial hyaluronan receptor-1 biomarker using GQD-AgNPrs conductive ink stabilized on the surface of cellulose.一种新型便携式免疫装置,用于识别淋巴管内皮透明质酸受体-1生物标志物,该装置使用稳定在纤维素表面的GQD-AgNPrs导电墨水。
RSC Adv. 2023 Oct 23;13(44):30925-30936. doi: 10.1039/d3ra06025j. eCollection 2023 Oct 18.
9
Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities-A Systematic Review.NECTIN蛋白在肝癌及其他实体恶性肿瘤中的临床意义:对预后的影响及新的治疗机会——一项系统综述
Cancers (Basel). 2023 Aug 5;15(15):3983. doi: 10.3390/cancers15153983.
10
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort.恩杂鲁胺治疗转移性尿路上皮癌:欧洲多中心真实世界患者队列中的生存情况与安全性
Eur Urol Open Sci. 2023 May 17;53:31-37. doi: 10.1016/j.euros.2023.04.018. eCollection 2023 Jul.